Sovenyr
Subscribe
Signal
2026-07-24
EPO Patents
[EPO] ENGINEERED CELLS FOR THE PRODUCTION OF CD4+ T CELLS AND CD4+ TREGS
Part of
Engineered T Cell Immunotherapy Advances
Open primary source
Read on Substack